The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of guinea pig mast cells: Involvement of nitric oxide and eicosanoids

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 1, 2004, Pages 256-264

  Vannacci, Alfredo ^a   Giannini, Lucia ^a   Passani, Maria Beatrice ^a   Di Felice, Annamaria ^a   Pierpaoli, Simone ^a   Zagli, Giovanni ^a   Fantappiè, Ornella ^a   Mazzanti, Roberto ^a   Masini, Emanuela ^a   Mannaioni, Pier Francesco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ARGININE; CANNABINOID; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; HISTAMINE; ICOSANOID; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROSTAGLANDIN E2; ROFECOXIB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GUINEA PIG; HISTAMINE RELEASE; IMMUNE RESPONSE; MALE; MAST CELL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; RECEPTOR BLOCKING; SENSITIZATION;

ANIMALS; ARACHIDONIC ACIDS; BLOTTING, WESTERN; CYCLOHEXANOLS; EICOSANOIDS; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; GUINEA PIGS; IMMUNITY; IMMUNOSUPPRESSIVE AGENTS; MALE; MAST CELLS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RECEPTOR, CANNABINOID, CB2;

EID: 4644254057     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.068635     Document Type: Article

References (41)

1. Aloe L, Leon A, and Levi-Montalcini R (1993) A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 39:0145-0147.
2. Barth F and Rinaldi-Carmona M (1999) The development of cannabinoid antagonists. Curr Med Chem 6:745-755.
3. Bisogno T, Maurelli S, Melck D, De Petrocellis L, and Di Marzo V (1997) Biosynthesis, uptake and degradation of anandamide and palmitoylethanolamide in leukocytes. J Biol Chem 272:3315-3323.
4. Brooks AC, Whelan CJ, and Purcell WM (1999) Reactive oxygen species generation and histamine release by activated mast cells: modulation by nitric oxide synthase inhibition. Br J Pharmacol 128:585-590.
5. Bueb JL, Lambert DM, and Tschirhart EJ (2001) Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. Biochim Biophys Acta 23;1538:252-259.
6. Coffey RG, Yamamoto Y, Snella E, and Pross S (1996) Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 52:743-751.
7. 1 on histamine release from rat and guinea pig mast cells. Int Arch Allergy Appl Immunol 72:289-293.
8. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, and Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
9. Fimiani C, Liberty T, Aquirre AJ, Amin I, Ali N, and Stefane GB (1999a) Opiate, cannabinoid and eicosanoid signaling converges on common intracellular pathways nitric oxide coupling. Prostaglandins Other Lipid Mediat 57:23-34.
10. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, and Stefano GB (1999b) Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11:189-193.
11. 45calcium uptake by mast cells. J Physiol 271:193-214.
12. Ganley O, Graessle O, and Robinson H (1958) Anti-inflammatory activity on compounds obtained from egg yolk, peanut oil, and soybean lecithin. J Lab Clin Med 51:709-714.
13. Gardner B, Zhu LX, Sharma S, Tashkin DP, and Dubinett SM (2003) Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. FASEB J 17:2157-2159.
14. Gilchrist M, Savoie M, Nohara O, Wills FL, Wallace JL, and Befus AD (2002) Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J Leukoc Biol 71:618-624.
15. Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, and Brune K (2002) A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454:153-163.
16. Iversen L and Chapman V (2002) Cannabinoids: a real prospect for pain relief? Curr Opin Pharmacol 2:50-55.
17. Jenkins DC, Charles SA, Baylis SA, Lelchuk R, Radomski MW, and Moncada S (1994) Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70:847-849.
18. Kaliner M (1979) Human lung tissue and anaphylaxis: cyclic nucleotide response and prostaglandin synthesis. Monogr Allergy 14:119-121.
19. Klein TW, Friedman H, and Specter S (1998) Marijuana, immunity and infection. J Neuroimmunol 83:102-115.
20. Kozak KR, Rowlinson SW, and Marnett LJ (2000) Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275:33744-33749.
21. Lau AH and Chow SS (2003) Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. Eur J Pharmacol 464:229-235.
22. Liu Q, Chan ST, and Mahendran R (2003) Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines. Carcinogenesis 24:637-642.
23. 1 on compound 48-80-induced histamine release from rat peritoneal mast cells in vitro. Biochem Pharmacol 20:2287-2297.
24. Lowry O, Rosebrough N, Farr A, and Randall P (1951) Protein measurement with the foin-phenol reagent. J Biol Chem 193:265-275.
25. Masini E, Di Bello MG, Pistelli A, Raspanti S, Gambassi F, Mugnai L, Lupini M, and Mannaioni PF (1994) Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol 45:41-53.
26. Nahas GG, Suciu-Foca N, Armand JP, and Morishima A (1974) Inhibition of cellular mediated immunity in marihuana smokers. Science (Wash DC) 183:419-420.
27. Ndisang JF, Gai P, Berni L, Mirabella C, Baronti R, Mannaioni PF, and Masini E (1999) Modulation of the immunological response of guinea pig mast cells by carbon monoxide. Immunopharmacology 43:65-73.
28. 2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol 53:493-500.
29. Prevot V, Rialas CM, Croix D, Salzet M, Dupouy JP, Poulain P, Beauvillain JC, and Stefano GB (1998) Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res 790:236-244.
30. Ramar R, Brune K, Pahl A, and Hinz B (2001) R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochem Biophys Res Commun 286:1144-1152.
31. Salvemini D, Masini E, Pistelli A, Mannaioni PF, and Vane J (1991) Nitric oxide: a regulatory mediator of mast cell reactivity. J Cardiovasc Pharmacol 17:8258-8264.
32. Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, and Turner H (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170:4953-4962.
33. Someya A, Horie S, and Murayama T (2002) Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. Eur J Pharmacol 450:131-139.
34. Stefano GB, Liu Y, and Goligorsky MS (1996) Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia and human monocytes. J Biol Chem 271:19238-19242.
35. Stefano GB, Salzet B, and Salzet M (1997) Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. Brain Res 753:219-224.
36. Stefano GB, Salzet M, Magazine HI, and Bilfinger TV (1998) Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 31:813-820.
37. 2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 275:605-612.
38. Vannacci A, Giannini L, Masini E, and Mannaioni PF (2003a) Cannabinoid-induced activation of ERK and AKT in mast cells may be mediated by intracellular NO production. J Immunol 171:2767.
39. Vannacci A, Passani MB, Pierpaoli S, Giannini L, Mannaioni PF, and Masini E (2003b) Nitric oxide modulates the inhibitory effect of cannabinoids on the immunological activation of guinea pig mast cells. Inflamm Res 52 (Suppl 1):S07-S08.
40. Vannacci A, Zagli G, Marzocca C, Pierpaoli S, Passani MB, Mannaioni PF, and Masini E (2002) Down-regulation by cannabinoids of the immunological activation of human basophils and guinea pig mast cells. Inflamm Res 51 (Suppl 1):S09-S10.
41. Wescott S and Kaliner M (1981) The effects of histamine and prostaglandin D2 on rat mast-cell cyclic AMP and mediator release. J Allergy Clin Immunol 68:383-391.